Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Visceral pain pathways" refer to the complex and distributed circuits by which noxious (painful) stimuli arising from the internal organs (viscera) are transduced, transmitted, and processed by the nervous system. These pathways involve a broad array of molecular mediators (e.g., cytokines, prostaglandins, neuropeptides), ion channels (including transient receptor potential vanilloid 1 [TRPV1] and acid-sensing ion channels [ASICs]), and neural circuits comprising afferent neurons, spinal and supraspinal processing centers, and regulatory feedback. Chronic dysregulation or sensitization of these pathways underpins visceral hypersensitivity and chronic pain conditions such as irritable bowel syndrome, where altered pain signaling and neuroimmune interactions contribute to morbidity[1][3][4][5]. The terminology does not represent a single druggable target but rather encompasses multiple molecular interventions currently under exploration for the treatment of chronic visceral pain syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on visceral pain pathways.